URS
SAGE

Utah Retirement Systems’s Sage Therapeutics SAGE Stock Holding History

Utah Retirement Systems’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,700
Closed -$202K – 995
2021
Q1 		$202K Buy
2,700
+100
+4% +$8.2K ﹤0.01% 945
2020
Q4 		$225K Buy
+2,600
New +$192K ﹤0.01% 894
2020
Q3 		– Sell
-9,712
Closed -$404K – 970
2020
Q2 		$404K Hold
9,712
– – 0.01% 857
2020
Q1 		$279K Sell
9,712
-100
-1% -$5.79K 0.01% 871
2019
Q4 		$709K Buy
9,812
+300
+3% +$36.9K 0.01% 832
2019
Q3 		$1.33M Buy
9,512
+100
+1% +$16.7K 0.03% 619
2019
Q2 		$1.72M Buy
9,412
+185
+2% +$31.6K 0.03% 515
2019
Q1 		$1.47M Buy
9,227
+827
+10% +$120K 0.03% 565
2018
Q4 		$805K Hold
8,400
– – 0.02% 733
2018
Q3 		$1.19M Hold
8,400
– – 0.02% 651
2018
Q2 		$1.31M Buy
+8,400
New +$1.32M 0.03% 605

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Utah Retirement Systems's SAGE Position: Q2 2021 in Review

Utah Retirement Systems sold out of Sage Therapeutics (SAGE) in Q2 2021, closing a stake of 2,700 shares — an estimated $202K sold.

Utah Retirement Systems first reported a position in SAGE in Q2 2018 and held it in 11 quarters. The position peaked at $1.72M in Q2 2019. 257 funds tracked by Wall St. Rank hold SAGE as of Q2 2021.

  • Utah Retirement Systems reported no remaining Sage Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Utah Retirement Systems sold 2,700 Sage Therapeutics shares in Q2 2021, an estimated $202K.
  • Utah Retirement Systems first reported a position in Sage Therapeutics in Q2 2018 and held it in 11 quarters.
  • Utah Retirement Systems's Sage Therapeutics position peaked at $1.72M in Q2 2019.
  • 257 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2021.

Based on Utah Retirement Systems's 13F filing for Q2 2021, filed 16 Aug 2021.